Medicine & Life Sciences
ACT-451840
37%
Antimalarials
100%
artemisinine
57%
Artemisinins
6%
Artesunate
10%
ATP Binding Cassette Transporter, Subfamily B, Member 1
8%
Bacillus subtilis
8%
Cleavage And Polyadenylation Specificity Factor
14%
Clustered Regularly Interspaced Short Palindromic Repeats
14%
Combination Drug Therapy
7%
Coronavirus
29%
Cytomegalovirus
7%
Detergents
8%
dihydroorotate dehydrogenase
40%
Drug Resistance
8%
DSM265
66%
Endoplasmic Reticulum
7%
Enzymes
5%
Epidemiology
6%
Falciparum Malaria
11%
Gene Editing
14%
Glutathione Transferase
8%
Hemeproteins
12%
In Vitro Techniques
14%
Infections
6%
Malaria
33%
Mefloquine
6%
Membrane Glycoproteins
8%
Membrane Proteins
14%
Membranes
12%
Mutation
13%
Parasites
58%
Pharmaceutical Preparations
10%
Pharmacokinetics
8%
Piperazine
11%
Plasmodium
30%
Plasmodium falciparum
82%
Point Mutation
11%
Proteasome Endopeptidase Complex
27%
Proteasome Inhibitors
26%
Proteins
7%
Proteolysis
10%
quinoline
11%
Quinolines
6%
Safety
7%
Severe Acute Respiratory Syndrome
25%
Tetracycline
8%
Therapeutics
9%
Trophozoites
6%
Vivax Malaria
10%
Agriculture & Biology
animal models
6%
antimalarials
18%
artemisinin
13%
falciparum malaria
5%
parasites
8%
Plasmodium
9%
Plasmodium falciparum
16%
proteasome endopeptidase complex
17%
proteasome inhibitors
16%
protein degradation
8%
Severe acute respiratory syndrome coronavirus
13%
therapeutics
8%
ubiquitin
5%